*Koichi Muramatsu¹, Saki Yamada¹, Waka Lin¹, Toshihiko Hosoya¹ (1. Biomedical R&D dept, Ricoh Company, Ltd., Kanagawa, Japan)

*Ayaka Higa¹, Yuko Sekino^2,5, Noriko Koganezawa^1,3,4, Yoshiyasu Nagashima², Hiroyuki Yamazaki⁶, Reiko T Ropponngi^4,7, Shin-Ichi Sekizawa², Tomoaki Shirao^1,4 (1. AlzMed,Inc., Tokyo, Japan, 2. Grad Sch Agri Life Sci, Univ of Tokyo, Tokyo, Japan, 3. Grad Sch Front Sci, Univ of Tokyo, Tokyo, Japan, 4. Gunnma Univ Grad Sch of Med, Maebashi, Japan, 5. Inst for Drug Dis Innov, Tokyo, Japan, 6. Dept Nurs, Gunma Pref Coll Health Sci, Maebashi, Japan, 7. Gunma Univ Init of Adv Res, Gunma Univ, Maebashi, Japan)

*Yuji Kurihara^1,2, Yuki Kawaguchi^1,3, Junpei Matsubayashi^1,3, Yuki Ohta⁴, Nana Kawasaki⁴, Nobuharu Suzuki⁵, Yuki Fujita², Kohtaro Takei^1,3 (1. Molecular Medical Bioscience Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan, 2. Department of Anatomy & Developmental Biology, Faculty of Medicine, Shimane University, Izumo, Japan, 3. Department of Regenerative Medicine, Graduate School of Medicine, Yokohama City University, Yokohama, Japan, 4. Laboratory of Biopharmaceutical and Regenerative Sciences, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan, 5. Clinical Bioanalysis and Molecular Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan)